Results 111 to 120 of about 1,541,059 (150)

AMAP Assessment 2013: Arctic Ocean Acidification. Arctic Monitoring and Assessment Programme (AMAP) [PDF]

, 2013
AMAP,, Hall-Spencer, Jason
core  

Evaluations of Community-based Healthcare Management for Patients with Chronic Viral Hepatitis - Shanghai Municipality, China, 2012-2023. [PDF]

China CDC Wkly
Ren H, Xu D, Qu L, Shen X, Chen K, Pan Q, Hu J, Shi Y, Li J, Chen X.   +9 more
europepmc   +1 more source

Reducing the Risk of Overt Hepatic Encephalopathy Recurrence: A Narrative Review. [PDF]

J Clin Transl Hepatol
Pyrsopoulos NT, Gunn N, Jalal PK, Catinis GE.   +3 more
europepmc   +1 more source

Evaluation of tourism competitiveness and analysis of obstacle factors in border counties of Northeast China. [PDF]

Front Public Health
Gong Y, Man S, Liu W.
europepmc   +1 more source

Exploiting predictive metabolomics of pearl millet phenotypic traits using untargeted profiling across a Brazilian germplasm panel. [PDF]

Metabolomics
Pinheiro Costa Pimentel M, Martins Abdão Dos Passos A, Prigent S, Cassan C, Dessaune Tardin F, Simões Larraz Ferreira M, Pétriacq P, Barros Santos MC.   +7 more
europepmc   +1 more source

Satellite mapping of every building's function in urban China reveals deep built environment disparities. [PDF]

Nat Commun
Li Z, Li L, Hu T, Cheng M, He W, Qiu T, Zhang L, Zhang H.   +7 more
europepmc   +1 more source

Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium. [PDF]

Hepatology
Kanwal F, Feng Z, Hoshida Y, Chhatwal J, Wong VW, Ioannou GN, Nahon P, Lotter W, Ning J, Ning J, Taouli B, Marquez G, Fu SW, Singal AG.   +13 more
europepmc   +1 more source

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis [PDF]

Journal of Hepatology, 2020
Hepatocellular carcinoma (HCC) is the leading cause of death in patients with chronic hepatitis. In this international collaboration, we sought to develop a global universal HCC risk score to predict the HCC development for patients with chronic hepatitis.A total of 17,374 patients, comprising 10,578 treated Asian patients with chronic hepatitis B (CHB)
Chaonan Zhu, Junqi Niu
exaly   +13 more sources

Some of the next articles are maybe not open access.

Related searches:

aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients

Clinical Gastroenterology and Hepatology, 2023
The changes in liver stiffness measurement (LSM) are unreliable to estimate regression of fibrosis during antiviral treatment for chronic hepatitis B (CHB) patients. The age-male-albumin-bilirubin-platelets score (aMAP), as an accurate hepatocellular carcinoma risk score, may reflect the liver fibrosis stage.
Wen-Yue Liu, Howard Ho‐Wai Leung
exaly   +3 more sources

aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C

Hepatology Research, 2021
AbstractAimsHepatocellular carcinoma (HCC) can still occur in hepatitis C virus (HCV) patients who have achieved a sustained virologic response (SVR), which remains an important clinical issue in the direct‐acting antivirals era. The current study investigated the clinical utility of the aMAP score (consisting of age, male, albumin–bilirubin, and ...
Ayumi Sugiura, Takeji Umemura, Yuki Yamashita   +2 more
exaly   +3 more sources